Thomas Shaw Buys 35,000 Shares of Retractable Technologies (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas Shaw bought 35,000 shares of Retractable Technologies stock in a transaction dated Tuesday, October 28th. The stock was acquired at an average price of $0.92 per share, for a total transaction of $32,200.00. Following the completion of the acquisition, the chief executive officer owned 15,802,891 shares in the company, valued at approximately $14,538,659.72. The trade was a 0.22% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Retractable Technologies Stock Performance

Retractable Technologies stock opened at $0.87 on Friday. The company’s 50-day moving average price is $0.87 and its 200-day moving average price is $0.76. Retractable Technologies, Inc. has a twelve month low of $0.56 and a twelve month high of $1.14. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The company has a market cap of $26.05 million, a PE ratio of -1.61 and a beta of 1.45.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.